Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.19.3
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Deferred Offering Costs $ 21,000   $ 21,000   $ 41,000
Warrant [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8,906,955 8,601,813 8,906,955 8,601,813  
Antidilutive Securities Preferred Stock [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 250,000   250,000    
Restricted Stock Units (RSUs) [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 241,132 943,352 241,132 943,352  
Accounts Receivable [Member] | Customer Concentration Risk One [Member]          
Concentration Risk, Percentage     48.00%   47.00%
Accounts Receivable [Member] | Customer Concentration Risk Two [Member]          
Concentration Risk, Percentage     45.00%   42.00%
Sales Revenue, Net [Member] | Customer Concentration Risk One [Member]          
Concentration Risk, Percentage 56.00% 51.00% 54.00% 59.00%  
Sales Revenue, Net [Member] | Customer Concentration Risk Two [Member]          
Concentration Risk, Percentage 20.00% 45.00% 28.00% 32.00%  
Sales Revenue, Net [Member] | Customer Concentration Risk Three [Member]          
Concentration Risk, Percentage 17.00%   11.00%